Methods, compositions, and delivery systems for therapeutic skin treatments
Disclosed are skincare formulations, delivery systems and treatment methods containing an oligopeptide and a combination of antioxidants for topical application to the skin before and/or after dermatological procedures that affect the skin's barrier. The systems herein alleviate discomfort and enable rapid healing of irritated and damaged skin, and provide improved treatment outcomes for dermatological procedures. The disclosed topical formulations, delivery systems, and methods thereof provide enhanced penetration of the active ingredients to the skin while maintaining skin moisture and protecting sensitive skin after dermatological procedures for improvement of aesthetic skin properties. Also provided are methods for therapeutic treatment of dermatological conditions by topically applying, using, for example, a pre-moistened bio-cellulose mask, a formulation comprising (% w/w) at least 0.0001% palmitoyl sh-tripeptide-4 amide on an active basis and at least 0.1% Camellia sinensis leaf extract.
1. A topical formulation for therapeutic treatment of skin in dermatological procedures, comprising (% w/w)
0.001%-10% sodium hyaluronate,
an oligopeptide, wherein the oligopeptide is 0.0001%-10% palmitoyl sh-tripeptide-4 amide on an active basis,
one or more antioxidants, wherein the one or more antioxidants is between 0.1%-10% w/w and comprises one or more of Camellia sinensis leaf extract, resveratrol, ectoin, Cucumis satvius fruit extract, ergothioneine, Phyllanthus emblica fruit extract,
10%-99% purified water;
0.001%-75% hydrolyzed sodium hyaluronate;
0.001%-99% Camellia sinensis leaf extract;
0.001%-5.0% resveratrol;
0.001%-5% ectoin;
0.001%-5% ergothioneine;
0.001%-5% bisabolol;
0.001%-99% Cucumis satvius fruit extract;
0.001%-99% sodium pyrrolidone carboxylic acid (PCA);
0.001%-99% Chamomila recutita flower extract;
0.001%-99% comfrey extract;
0.001%-99% yucca glauca root extract;
0.001%-5% Phyllanthus emblica fruit extract;
0.001%-5% caffeine;
0%-2% sodium phosphate;
0%-0.5% potassium hydroxide;
0.0%-3.5% phenylcarbinol;
0.0%-0.5% sodium benzoate;
0.0%-0.3% disodium Ethylenediaminetetraacetic acid (EDTA); and
0.01%-10% polysorbate 20.
2. The formulation of claim 1 , comprising (% w/w):
82.41% purified water;
1.00% hydrolyzed sodium hyaluronate;
0.10% sodium hyaluronate;
0.01% Camellia sinensis leaf extract;
0.01% resveratrol;
4.00% palmitoyl sh-tripeptide-4 amide;
0.01% ectoin;
0.01% ergothioneine;
0.20% bisabolol;
0.01% Cucumis satvius fruit extract;
0.01% sodium pyrrolidone carboxylic acid (PCA);
0.01% Chamomila recutita flower extract;
0.01% comfrey extract ( Symphytum officinale leaf extract, Leuconostoc /radish root ferment filtrate);
0.01% yucca glauca root extract;
0.10% Phyllanthus emblica fruit extract;
0.01% caffeine;
0.638% sodium phosphate;
0.226% potassium hydroxide;
0.20% phenylcarbinol;
0.05% sodium benzoate;
0.05% disodium Ethylenediaminetetraacetic acid (EDTA); and
0.70% polysorbate 20.
3. A sheet for therapeutic treatment of skin in dermatological procedures, comprising the sheet structured for topical application to skin selected for a dermatological procedure, the sheet being pre-moistened with a therapeutically effective amount of a formulation of claim 1 .
4. The sheet of claim 3 , wherein the sheet is a biocellulose sheet and is structured as a facial mask.
5. The sheet of claim 3 , wherein the formulation and/or sheet pre-moistened with the formulation is sterilized.
6. The topical formulation of claim 1 , wherein the formulation is sterile.
7. The topical formulation of claim 1 , wherein the formulation is a sheet.